Manufacturing news briefs – stories you might have missed

LBT Innovations extends analysis device uses Medical device manufacturer LBT Innovations has applied to the US Food and Drug Administration to extend the approved use of its APAS laboratory device which uses artificial intelligence to automate microbiology laboratory tests. The Adelaide company is seeking to add detection of Methicillin-resistant Staphylococcus aureus (MRSA) bacteria to APAS’s…

JAT embarks on anti-viral food R&D

While companies rush to meet short-term opportunities opened up by the arrival of the Covid-19 coronavirus, China exporter Jatenergy has embarked on a R&D programme to develop food supplements with anti-viral properties. The company, which exports a wide range of Australian products to China including milk-based foods, will work with researchers at the University of…

CSIRO begins testing Covid-19 vaccines as part of global effort

By Peter Roberts In an exciting development Australia’s CSIRO has begun testing potential vaccines against the Covid-19 coronavirus at its Australian Animal Health Laboratory (AAHL) facility in Geelong. Testing in the biosecure facility originally built to contain the world’s most harmful plant and animal diseases is part of a global effort led by the interational Coalition…

Drug companies should drop their patents and collaborate to fight coronavirus

As the coronavirus pandemic continues to claim victims around the world, the race is on to produce the right medicines to fight it. This includes developing a vaccine to stop people from falling ill in the first place, testing kits and drugs to treat those that fall ill with COVID-19.